118 related articles for article (PubMed ID: 6157944)
1. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia.
Tonkin AM; Aylward PE; Joel SE; Heddle WF
J Cardiovasc Pharmacol; 1980; 2(5):473-86. PubMed ID: 6157944
[TBL] [Abstract][Full Text] [Related]
2. The prophylaxis of AV nodal re-entry tachycardia.
Tonkin AM; Shorne L
Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
[TBL] [Abstract][Full Text] [Related]
3. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Gomes JA; Hariman RJ; Kang PS; Chowdry IH
J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
[TBL] [Abstract][Full Text] [Related]
4. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
Wellens HJ; Tan SL; Bär FW; Düren DR; Lie KI; Dohmen HM
Br Heart J; 1977 Oct; 39(10):1058-66. PubMed ID: 911555
[TBL] [Abstract][Full Text] [Related]
5. Metoprolol in the treatment and prophylaxis of paroxysmal reentrant supraventricular tachycardia.
Gmeiner R; Ng CK
J Cardiovasc Pharmacol; 1982; 4(1):5-13. PubMed ID: 6176799
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway.
Wu D; Kou HC; Yeh SJ; Lin FC; Hung JS
Circulation; 1983 Feb; 67(2):426-33. PubMed ID: 6848233
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic characteristics of verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus.
Yamabe H; Tanaka Y; Okumura K; Morikami Y; Kimura Y; Hokamura Y; Ogawa H
Am J Cardiol; 2005 Jun; 95(12):1425-30. PubMed ID: 15950564
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node.
DiMarco JP; Sellers TD; Belardinelli L
J Am Coll Cardiol; 1984 Jun; 3(6):1551-5. PubMed ID: 6715711
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
11. Clinical and electrophysiologic characteristics and long-term efficacy of slow-pathway catheter ablation in patients with spontaneous supraventricular tachycardia and dual atrioventricular node pathways without inducible tachycardia.
Lin JL; Stephen Huang SK; Lai LP; Ko WC; Tseng YZ; Lien WP
J Am Coll Cardiol; 1998 Mar; 31(4):855-60. PubMed ID: 9525559
[TBL] [Abstract][Full Text] [Related]
12. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.
Hirao K; Okishige K; Suzuki F; Hiejima K
Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():819-25. PubMed ID: 1931758
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
Belhassen B; Glick A; Laniado S
Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
[TBL] [Abstract][Full Text] [Related]
15. A shared pathway in atrioventricular nodal reentrant tachycardia and atrial flutter: implications for pathophysiology and therapy.
Interian A; Cox MM; Jimenez RA; Duran A; Levin E; Garcia O; Cooper DK; Castellanos A; Myerburg RJ
Am J Cardiol; 1993 Feb; 71(4):297-303. PubMed ID: 8427171
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
Sakurai M; Yasuda H; Kato N; Nomura A; Fujita M; Nishino T; Fujita K; Koike Y; Saito H
Am Heart J; 1983 Apr; 105(4):619-28. PubMed ID: 6837416
[TBL] [Abstract][Full Text] [Related]
17. AV nodal reentrant tachycardia using three different AV nodal pathways.
Kühlkamp V; Haasis R; Seipel L
Eur Heart J; 1990 Sep; 11(9):857-62. PubMed ID: 2226514
[TBL] [Abstract][Full Text] [Related]
18. Initiation of atrioventricular nodal reentrant tachycardia in patients with discontinuous anterograde atrioventricular nodal conduction curves with and without documented supraventricular tachycardia: observations on the role of a discontinuous retrograde conduction curve.
Brugada P; Heddle B; Green M; Wellens HJ
Am Heart J; 1984 Apr; 107(4):685-97. PubMed ID: 6702563
[TBL] [Abstract][Full Text] [Related]
19. [Three AV-nodal pathways in a patient with atypical AV-nodal reentry tachycardia].
Weismüller P; Pu JL; Grossmann G; Höher M; Kochs M; Hombach V
Z Kardiol; 1995 Sep; 84(9):724-8. PubMed ID: 8525674
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
